Hypothalamic–pituitary–adrenal axis activity, personality traits, and BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in metabolically obese normal-weight women

被引:3
作者
Joanna Porzezińska-Furtak
Barbara Krzyżanowska-Świniarska
Tomasz Miazgowski
Krzysztof Safranow
Ryszard Kamiński
机构
[1] Pomeranian Medical University,Department of Hypertension and Internal Medicine
[2] Pomeranian Medical University,Department of Biochemistry & Medical Chemistry
[3] West Pomeranian Institute of Psychotherapy,undefined
来源
Endocrine | 2014年 / 47卷
关键词
Cortisol; Copeptin; Personality traits; Glucocorticoid receptor gene; Metabolically obese normal-weight;
D O I
暂无
中图分类号
学科分类号
摘要
We sought associations among metabolic profiles, copeptin levels, emotional control, personality traits, and hypothalamic–pituitary–adrenal axis activity in metabolically obese normal-weight young women (MONW). We assessed body composition, including fat-free mass; body fat (BF) and android and gynoid fat depots; fasting blood glucose, insulin, copeptin, cortisol (baseline and after dexamethasone), adrenocorticotropin (ACTH), triglycerides, total cholesterol, low- (LDL) and high-density (HDL) lipoproteins; and the BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in 59 MONW and 71 healthy women aged 20–40 years. We also evaluated personality traits using the NEO-Five Factor Inventory and the subjective extent of emotional suppression by the Courtauld Emotional Control Scale. Compared to the controls, MONW had significantly higher insulin, cholesterol, LDL, triglycerides, and waist circumference, but lower HDL. MONW also had increased BF (>30 % of weight) and unfavorable regional fat distribution with excess android fat. The android/BF ratio was 8.29 % (MONW) versus 7.89 % (controls) (p = 0.005), while the gynoid/BF ratio was 31.99 versus 34.1 %, respectively (p = 0.008). Despite similar ACTH levels in both groups, MONW had higher cortisol levels both at the baseline (p < 0.001) and in the dexamethasone suppression test (p = 0.003). Copeptin levels and the distribution of glucocorticoid receptor polymorphisms were similar in both groups. There were also no significant differences in psychological features between MONW and controls. In conclusion, the MONW phenotype was associated with hypothalamic–pituitary–adrenal axis dysregulation, unfavorable metabolic profiles, and fat accumulation, but normal distribution of glucocorticoid receptor gene polymorphisms and copeptin levels, and no significant differences in psychological features between MONW and controls.
引用
收藏
页码:315 / 321
页数:6
相关论文
共 215 条
[1]
Ruderman NB(1982)Obesity associated disorders in normal weight individuals: some speculations Int. J. Obes. 6 151-157
[2]
Brechtold P(2003)Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance Diabetes Care 26 2341-2344
[3]
Schneider SH(2004)Metabolic and behavioral characteristic of metabolically obese but normal-weight women J. Clin. Endocrinol. Metab. 89 5013-5020
[4]
Katsuki A(1998)Phenotypic characteristics associated with insulin resistance in metabolically obese but normal weight young women Diabetes 48 2210-2214
[5]
Sumida Y(2006)Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease J. Clin. Endocrinol. Metab. 91 2906-2912
[6]
Urakawa H(2004)Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual Diabetes Care 27 2222-2228
[7]
Conus F(1998)The metabolically obese, normal-weight individual revisited Diabetes 47 699-713
[8]
Allison DB(2008)Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals Obesity 16 1881-1886
[9]
Rabasa-Lhoret R(2003)Lean adolescents with increased risk for metabolic syndrome Arch. Latinoam. Nutr. 53 39-46
[10]
St-Onge M(2003)Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women Diabetes Care 26 372-379